| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/31/2004 | CA2293397C C-4''-substituted macrolide derivatives |
| 08/31/2004 | CA2192446C Antiviral dendrimers |
| 08/28/2004 | CA2421086A1 Chicken rna polymerase i promoter and its use |
| 08/27/2004 | CA2458001A1 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 08/26/2004 | WO2004072272A1 Bacterial compositions |
| 08/26/2004 | WO2004072243A2 Macrocyclic hepatitis c serine protease inhibitors |
| 08/26/2004 | WO2004072113A1 Method and compositions for boosting immune response |
| 08/26/2004 | WO2004072078A1 Pyrazolotriazine derivatives, methods for production and uses thereof |
| 08/26/2004 | WO2004072070A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives |
| 08/26/2004 | WO2004072052A2 Isoxasole-containing thiourea inhibitors useful for treatment of varicella zoster virus |
| 08/26/2004 | WO2004072048A1 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazoline-4-yl) acetic acids as anti-viral agents, especially against cytomegalo viruses |
| 08/26/2004 | WO2004071510A1 Pharmaceutical composition comprising immunosuppressants for the treatment of dermatophytosis |
| 08/26/2004 | WO2004071506A1 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 08/26/2004 | WO2004071503A1 Remedy for viral disease |
| 08/26/2004 | WO2004071458A2 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 08/26/2004 | WO2004071430A2 RNAi TARGETING OF VIRUSES |
| 08/26/2004 | WO2004071416A2 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 08/26/2004 | WO2004063336A3 Uses of deazapurines for the treatment of reperfusion injuries, osteoporosis and/or bone metastasis |
| 08/26/2004 | WO2004060487A3 Composition for the treatment of hiv or aids |
| 08/26/2004 | WO2004056349A3 Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents |
| 08/26/2004 | WO2004052288A3 2-nh-heteroarylimidazoles with antibacterial activity |
| 08/26/2004 | WO2004043355A3 Alpha, alpha-disubstituted benzylglycine derivatives as hiv protease inhibitors |
| 08/26/2004 | WO2004035598A3 Chalcomycin derivatives |
| 08/26/2004 | WO2004031356A3 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 08/26/2004 | WO2004029066A3 Bifunctional heterocyclic compounds and methods of making and using same |
| 08/26/2004 | WO2004018461A3 Antibacterial benzoic acid derivatives |
| 08/26/2004 | WO2004013310A3 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 08/26/2004 | WO2004011464A3 Novel substituted pyrazolo[1,5 a]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
| 08/26/2004 | WO2004004653A3 Methods for treating psychosis associated with interferon-alpha therapy |
| 08/26/2004 | WO2003092602A3 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 08/26/2004 | WO2003077859A3 Method of inducing an enhanced immune response against hiv |
| 08/26/2004 | WO2003070911A3 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r) |
| 08/26/2004 | WO2003045354A8 Micropherules containing a pleuromutilin derivative |
| 08/26/2004 | WO2002044334A3 Recombinant rsv virus expression systems and vaccines |
| 08/26/2004 | WO2001051003A3 Use of lipid conjugates in the treatment of disease |
| 08/26/2004 | US20040167341 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 08/26/2004 | US20040167335 For therapy and prophylaxis of herpes viral infections |
| 08/26/2004 | US20040167334 Heterocyclic acylsulfimides, processes for their preparation, compositions comprising them and their use as pesticides |
| 08/26/2004 | US20040167332 Boronic ester and acid compounds, synthesis and uses |
| 08/26/2004 | US20040167331 To inhibit virulence and reduce antibiotic resistance of mycothiol-producing bacteria |
| 08/26/2004 | US20040167228 aerosols containing atenolol, pindolol, esmolol, propranolol, or metoprolol that are used in inhalation therapy |
| 08/26/2004 | US20040167224 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 08/26/2004 | US20040167201 Pyrrolidine melanocortin-specific compounds |
| 08/26/2004 | US20040167176 Tricyclic compounds useful as angiotensin II agonists |
| 08/26/2004 | US20040167174 Substituted acylhydroxamic acids and method of reducing TNFalpha levels |
| 08/26/2004 | US20040167162 therapy for infection of adenovirus, rhinovirus ; using an (amino or hydroxy)quinoline compound |
| 08/26/2004 | US20040167160 Skin disorders; controlling cell differentiation; antidiabetic agents; cardiovascular disorders; anticancer agents; central nervous system disorders |
| 08/26/2004 | US20040167154 Urea substituted imidazoquinolines |
| 08/26/2004 | US20040167152 Mixture of a rapamycin compound with cosolvent and antioxidant |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167140 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides |
| 08/26/2004 | US20040167135 Dihydropyrimidines |
| 08/26/2004 | US20040167133 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/26/2004 | US20040167089 Immunostimulatory nucleic acid molecules |
| 08/26/2004 | US20040167065 human transferases and polynucleotides which identify and encode them; expression vectors, host cells, antibodies, agonists, and antagonists; diagnosing, treating, or preventing disorders associated with aberrant expression of the transferases |
| 08/26/2004 | US20040167062 such as anxiety disorder, attention deficit/hyperactivity disorder, autistic disorder, bipolar disorder, major depression, mood disorder, pervasive developmental disorder, psychotic disorder and schizophrenia by administering an antimicrobial composition optionally with a probiotic mixture |
| 08/26/2004 | US20040167034 Emulsion and dispersion formulations and method |
| 08/26/2004 | US20040166561 Novel intein and uses thereof |
| 08/26/2004 | US20040166171 Antiulcer agents; anaerobic infections |
| 08/26/2004 | US20040166122 Adenovirus formulations |
| 08/26/2004 | US20040166116 Polypeptides containing polymorphisms of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 08/26/2004 | DE10305785A1 New 2-(2-phenylpiperanyl-3-phenyl-dihydroquinazolinyl)-acetic acid derivatives, useful as antiviral agents, especially effective against human cytomegalovirus infections |
| 08/26/2004 | CA2640585A1 Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspirol{4,4}-non-ene-4-one |
| 08/26/2004 | CA2515761A1 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 08/26/2004 | CA2515728A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives |
| 08/26/2004 | CA2515368A1 Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 08/26/2004 | CA2515216A1 Macrocyclic hepatitis c serine protease inhibitors |
| 08/26/2004 | CA2514912A1 Rnai targeting of viruses |
| 08/25/2004 | EP1449922A2 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis |
| 08/25/2004 | EP1449889A1 ANTI−BACTERIAL COMPOSITE PARTICLES AND ANTI−BACTERIAL RESIN COMPOSITION |
| 08/25/2004 | EP1449835A2 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds |
| 08/25/2004 | EP1449539A2 Prophylactic or therapeutic use of a Fas antagonist to inhibit Fas-mediated apoptosis |
| 08/25/2004 | EP1449537A2 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 08/25/2004 | EP1448984A2 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 08/25/2004 | EP1448784A1 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/25/2004 | EP1448595A1 Antimicrobial polypeptides from pseudoplectania nigrella |
| 08/25/2004 | EP1448588A2 Psma antibodies and protein multimers |
| 08/25/2004 | EP1448586A2 Therapeutic methods for nucleic acid delivery vehicles |
| 08/25/2004 | EP1448567A1 Method for the preparation of hexahydro-furo 2,3-b]furan-3-ol |
| 08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
| 08/25/2004 | EP1448564A2 Substituted indolizine-like compounds and methods of use |
| 08/25/2004 | EP1448556A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
| 08/25/2004 | EP1448550A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 08/25/2004 | EP1448548A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448545A1 Nf-kb inhibitors |
| 08/25/2004 | EP1448543A1 Products of condensations of hydroxycoumarin derivatives with aromatic and aliphatic dialdehydes, their preparation and antiviral action thereof |
| 08/25/2004 | EP1448539A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 08/25/2004 | EP1448536A1 Cyclopropyl-containing oxazolidinone antibiotics and derivatives thereof |
| 08/25/2004 | EP1448535A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 08/25/2004 | EP1448533A1 Dithiocarbamate derivatives and their use as antibacterial agents |
| 08/25/2004 | EP1448528A2 Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections |
| 08/25/2004 | EP1448524A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448521A1 Derivatives of andrimide and moiramide b having antibacterial properties |
| 08/25/2004 | EP1448513A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 08/25/2004 | EP1448508A1 Double esters |
| 08/25/2004 | EP1448504A2 Clusianon isomers and use thereof |
| 08/25/2004 | EP1448234A1 Formulations comprising a cephalosporin compound and their use in treating bacterial infections in cats and dogs |
| 08/25/2004 | EP1448231A1 Topical delivery of codrugs |
| 08/25/2004 | EP1448230A2 Adjuvanted antigenic meningococcal compositions |
| 08/25/2004 | EP1448216A2 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |